Asthma drug brings hope for COVID-19 treatment - DW (English)
A common asthma medication that can be used at home might be an effective treatment for early COVID-19 in adults, according to a study published in The Lancet medical journal. University of Oxford researchers found that patients who took the drug budesonide when their first COVID-19 symptoms started were less likely to need urgent medical care or hospitalization, and had a shorter recovery time. It also reduced the chance of persistent symptoms and fever. The randomized controlled trial involved 146 adults within seven days of the onset of mild COVID-19 symptoms. Half of the participants inhaled budesonide twice a day until their symptoms resolved, and the other half received the usual care given based on age, gender and existing illnesses. In the budesonide group, only one person needed urgent medical care, compared to 10 people in the group who received the standard care for COVID-19. Another University of Oxford study that has yet to be peer reviewed also found that inhaled...